RemeGen Co., Ltd. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (6)

Latest Posts

About This Stock More About This Stock
Week In Review: Under Pressure From US Congress, WuXi AppTec Resigns From BIO
Article By: ChinaBio® Today
Saturday, March 16, 2024 2:40 PM EDT
BIO, the global lobbying organization for biotechnology firms, forced WuXi AppTec to leave the group due to pressure from the US Congress. Also, Boehringer Ingelheim acquired an option to license drug candidates that treat symptoms of schizophrenia.
In this article: SOLTF, ASLN, REGMF, WUXIF, HNSPF
Read

Latest Tweets for $REGMF

No tweets yet!

PARTNER HEADLINES